Prevention of recurrent hepatitis C in Liver Transplant (LT) Recipients with Civacir: preliminary Results on Safety and Efficacy, Including Patients with Renal/Liver Dysfunction

Authors
Category Primary study
ConferenceThe Liver Meeting: 66th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD); 2015 Nov 13-17; San Francisco, CA, United States. Hepatology
Year 2015
This article has no abstract
Epistemonikos ID: 40cb979048fe6351300a2356c623bddfbe055860
First added on: Nov 24, 2021